Exelon Corporation (NYSE:EXC) after a big price and volume surge in December, the stock has gone sideways and consolidated in the 35-36.3 trading range. Yesterday, it closed just slightly below its the upper line of the consolidation range, which if broken could accelerate the price toward its August highs around the 37 area. (more…)
BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer. BLUE – Bluebird Bio Inc Fundamentals Previously closed at 47.72 Day's high 51.46 Day's low 47.61 P/E ratio NA EPS -2.44 Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will
ARDX– Ardelyx, Inc is a clinical stage bio-pharmaceutical company which develops therapeutic drugs for the treatment of Gastro-Intestinal and Cardio – Renal diseases. ARDX was given a “Buy”rating from Ladenburg Thalmann, and may be bullish today. ARDX – Ardelyx, Inc. Fundamentals Previously closed at 7.77 Day's high 8.02 Day's low 7.41 P/E ratio NA EPS -0.76 Analysts opinion Out of the 4 wall street analysts covering the stock, all
